Clinical Pearls for Febrile Neutropenia Prevention: An Algorithmic, Case-Based Guide to Navigating the Use of Myeloid Growth Factors- Identify factors that increase the risk of febrile neutropenia among patients with cancer who are receiving myelosuppressive chemotherapy.
Discuss appropriate uses of myeloid CSFs for febrile neutropenia prevention, including dosing and duration of use.
Describe strategies to ensure the cost-effective use of myeloid CSFs for febrile neutropenia prevention.
1.0 Free CEUs for Pharmacists
Expires 11/20/15
This activity is jointly provided by the University of North Carolina Eshelman School of Pharmacy and Paradigm Medical Communications, LLC
.
